Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells

Published:2006-10-01 Issue:19 Volume:12 Page:5869-5878
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Fiskus Warren,Pranpat Michael,Balasis Maria,Bali Purva,Estrella Veronica,Kumaraswamy Sandhya,Rao Rekha,Rocha Kathy,Herger Bryan,Lee Francis,Richon Victoria,Bhalla Kapil

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors;Epigenetics;2024-02-18

2. Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors;Expert Opinion on Pharmacotherapy;2024-01-22

3. Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies;Cellular and Molecular Life Sciences;2023-08-14

4. The importance of personalized medicine in chronic myeloid leukemia management: a narrative review;Egyptian Journal of Medical Human Genetics;2023-04-06

5. The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma;International Journal of Molecular Sciences;2022-12-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP